Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Lindemann
Tumors With AKT1E17K Mutations Are Rational Targets for Single Agent or Combination Therapy With AKT Inhibitors
Molecular Cancer Therapeutics
Cancer Research
Oncology
Influence of Diagnostic and Referral Delay on Timing of Surgical Repair and Outcomes After Bile Duct Injury in Laparoscopic Cholecystectomy, a Single Center Observational Study
HPB
Hepatology
Gastroenterology
Related publications
Combination Therapy With BRAF and MEK Inhibitors for Melanoma: Latest Evidence and Place in Therapy
Therapeutic Advances in Medical Oncology
Oncology
Potent Antitumor Effect of Combination Therapy With Sub‑optimal Doses of Akt Inhibitors and Pomalidomide Plus Dexamethasone in Multiple Myeloma
Oncology Letters
Cancer Research
Oncology
Synthetic Sickness or Lethality Points at Candidate Combination Therapy Targets in Glioblastoma
International Journal of Cancer
Cancer Research
Oncology
Inhibition of AKT Pathway Augments Combination Therapy
Otolaryngology - Head and Neck Surgery
Otorhinolaryngology
Surgery
Single Agent Therapy With Bevacizumab for the Treatment of Atypical Choroid Plexus Tumor
Kansas Journal of Medicine
An Effective Insulin Therapy in Combination With Sodium-Glucose Cotransporter 2 Inhibitors
Journal of Clinical Medicine Research
Heterogeneity Within AML With CEBPA Mutations; Only CEBPA Double Mutations, but Not Single CEBPA Mutations Are Associated With Favourable Prognosis
British Journal of Cancer
Cancer Research
Oncology
Venetoclax as a Single Agent and in Combination With PI3K-MTOR1/2 Kinase Inhibitors Against Ibrutinib Sensitive and Resistant Mantle Cell Lymphoma
British Journal of Haematology
Hematology
Combating Antimicrobial Resistance- Utility of Antimicrobial Combination Therapy and / or Β-Lactamase Inhibitors
International Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology
